• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Upsetting the Balance: How Modifiable Risk Factors Contribute to the Progression of Alzheimer's Disease.破坏平衡:可改变的风险因素如何导致阿尔茨海默病的进展。
Biomolecules. 2024 Feb 24;14(3):274. doi: 10.3390/biom14030274.
2
Progression of Alzheimer's disease, tau propagation, and its modifiable risk factors.阿尔茨海默病的进展、tau蛋白传播及其可改变的风险因素。
Neurosci Res. 2019 Apr;141:36-42. doi: 10.1016/j.neures.2018.08.005. Epub 2018 Aug 16.
3
Alzheimer's disease.阿尔茨海默病
Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14.
4
GABAergic dysfunction in excitatory and inhibitory (E/I) imbalance drives the pathogenesis of Alzheimer's disease.GABA 能神经传递功能障碍导致兴奋性和抑制性失衡,进而驱动阿尔茨海默病的发病机制。
Alzheimers Dement. 2020 Sep;16(9):1312-1329. doi: 10.1002/alz.12088. Epub 2020 Jun 16.
5
Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer's disease.褪黑素调节 Aβ 的产生/清除平衡和 Aβ 神经毒性:阿尔茨海默病的潜在治疗分子。
Biomed Pharmacother. 2020 Dec;132:110887. doi: 10.1016/j.biopha.2020.110887. Epub 2020 Nov 2.
6
Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer's disease.蛋白稳态失衡加剧阿尔茨海默病中神经元回路功能障碍和睡眠障碍。
Mol Neurodegener. 2023 Apr 21;18(1):27. doi: 10.1186/s13024-023-00617-4.
7
The Single Toxin Origin of Alzheimer's Disease and Other Neurodegenerative Disorders Enables Targeted Approach to Treatment and Prevention.阿尔茨海默病及其他神经退行性疾病的单毒素起源为治疗和预防提供了靶向方法。
Int J Mol Sci. 2024 Feb 27;25(5):2727. doi: 10.3390/ijms25052727.
8
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease.阿尔茨海默病发病机制的分子和细胞机制
Mol Neurodegener. 2020 Jul 16;15(1):40. doi: 10.1186/s13024-020-00391-7.
9
Beyond the sleep-amyloid interactions in Alzheimer's disease pathogenesis.阿尔茨海默病发病机制中睡眠-淀粉样蛋白相互作用之外的研究进展。
J Neurophysiol. 2019 Jul 1;122(1):1-4. doi: 10.1152/jn.00118.2019. Epub 2019 Mar 13.
10
Circadian and sleep dysfunction in Alzheimer's disease.阿尔茨海默病的昼夜节律和睡眠功能障碍。
Ageing Res Rev. 2020 Jul;60:101046. doi: 10.1016/j.arr.2020.101046. Epub 2020 Apr 16.

引用本文的文献

1
Multiple chronic conditions and polypharmacy in cognitively unimpaired older adults are associated with subsequent cognitive decline: results from the national alzheimer's coordinating center data.认知未受损的老年人中的多种慢性病和多重用药与随后的认知衰退相关:来自国家阿尔茨海默病协调中心数据的结果
Arch Gerontol Geriatr. 2025 Jul;134:105846. doi: 10.1016/j.archger.2025.105846. Epub 2025 Apr 3.
2
Extract Prescriptions Are Associated with Slower Progression of Dementia Severity-Analysis of Longitudinal Real-World Data.提取处方与痴呆严重程度进展较慢相关——纵向真实世界数据分析
Brain Sci. 2024 Dec 26;15(1):12. doi: 10.3390/brainsci15010012.

本文引用的文献

1
The efficacy and safety of anti-Aβ agents for delaying cognitive decline in Alzheimer's disease: a meta-analysis.抗淀粉样蛋白β(Aβ)药物延缓阿尔茨海默病认知衰退的疗效和安全性:一项荟萃分析。
Front Aging Neurosci. 2023 Nov 6;15:1257973. doi: 10.3389/fnagi.2023.1257973. eCollection 2023.
2
Anti-amyloid therapies for Alzheimer disease: finally, good news for patients.用于治疗阿尔茨海默病的抗淀粉样蛋白疗法:终于,给患者带来了好消息。
Mol Neurodegener. 2023 Jun 28;18(1):42. doi: 10.1186/s13024-023-00637-0.
3
Synaptic oligomeric tau in Alzheimer's disease - A potential culprit in the spread of tau pathology through the brain.阿尔茨海默病中的突触寡聚tau - 通过大脑传播 tau 病理学的潜在罪魁祸首。
Neuron. 2023 Jul 19;111(14):2170-2183.e6. doi: 10.1016/j.neuron.2023.04.020. Epub 2023 May 15.
4
sTREM2 is associated with amyloid-related p-tau increases and glucose hypermetabolism in Alzheimer's disease.sTREM2 与阿尔茨海默病中与淀粉样蛋白相关的 p-tau 增加和葡萄糖代谢亢进有关。
EMBO Mol Med. 2023 Feb 8;15(2):e16987. doi: 10.15252/emmm.202216987. Epub 2023 Jan 9.
5
Differential regulation of insulin signalling by monomeric and oligomeric amyloid beta-peptide.单体和寡聚淀粉样β肽对胰岛素信号传导的差异调节
Brain Commun. 2022 Sep 24;4(5):fcac243. doi: 10.1093/braincomms/fcac243. eCollection 2022.
6
Regional Precuneus Cortical Hyperexcitability in Alzheimer's Disease Patients.阿尔茨海默病患者的区域顶内沟皮质兴奋性过高。
Ann Neurol. 2023 Feb;93(2):371-383. doi: 10.1002/ana.26514. Epub 2022 Oct 18.
7
Inflammation From Peripheral Organs to the Brain: How Does Systemic Inflammation Cause Neuroinflammation?从外周器官到大脑的炎症:全身炎症如何引发神经炎症?
Front Aging Neurosci. 2022 Jun 16;14:903455. doi: 10.3389/fnagi.2022.903455. eCollection 2022.
8
Inflammation, tau pathology, and synaptic integrity associated with sleep spindles and memory prior to β-amyloid positivity.在β-淀粉样蛋白阳性之前,与睡眠纺锤波和记忆相关的炎症、tau 病理学和突触完整性。
Sleep. 2022 Sep 8;45(9). doi: 10.1093/sleep/zsac135.
9
Sleep: The Tip of the Iceberg in the Bidirectional Link Between Alzheimer's Disease and Epilepsy.睡眠:阿尔茨海默病与癫痫双向联系中的冰山一角。
Front Neurol. 2022 Apr 11;13:836292. doi: 10.3389/fneur.2022.836292. eCollection 2022.
10
APOE mediated neuroinflammation and neurodegeneration in Alzheimer's disease.载脂蛋白 E 介导的阿尔茨海默病中的神经炎症和神经退行性变。
Semin Immunol. 2022 Jan;59:101594. doi: 10.1016/j.smim.2022.101594. Epub 2022 Feb 26.

破坏平衡:可改变的风险因素如何导致阿尔茨海默病的进展。

Upsetting the Balance: How Modifiable Risk Factors Contribute to the Progression of Alzheimer's Disease.

机构信息

Psychiatry and Behavioral Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.

Alzheimer's Disease Research Center, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.

出版信息

Biomolecules. 2024 Feb 24;14(3):274. doi: 10.3390/biom14030274.

DOI:10.3390/biom14030274
PMID:38540695
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10968327/
Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder affecting nearly one in nine older adults in the US. This number is expected to grow exponentially, thereby increasing stress on caregivers and health systems. While some risk factors for developing AD are genetic, an estimated 1/3 of AD cases are attributed to lifestyle. Many of these risk factors emerge decades before clinical symptoms of AD are detected, and targeting them may offer more efficacious strategies for slowing or preventing disease progression. This review will focus on two common risk factors for AD, metabolic dysfunction and sleep impairments, and discuss potential mechanisms underlying their relationship to AD pathophysiology. Both sleep and metabolism can alter AD-related protein production and clearance, contributing to an imbalance that drives AD progression. Additionally, these risk factors have bidirectional relationships with AD, where the presence of AD-related pathology can further disrupt sleep and worsen metabolic functioning. Sleep and metabolism also appear to have a bidirectional relationship with each other, indirectly exacerbating AD pathophysiology. Understanding the mechanisms involved in these relationships is critical for identifying new strategies to slow the AD cascade.

摘要

阿尔茨海默病(AD)是一种神经退行性疾病,影响美国近九分之一的老年人。预计这一数字将呈指数级增长,从而增加护理人员和医疗系统的压力。虽然 AD 的一些风险因素是遗传的,但据估计,1/3 的 AD 病例归因于生活方式。这些风险因素中的许多在 AD 的临床症状出现之前几十年就出现了,针对这些因素可能为减缓或预防疾病进展提供更有效的策略。这篇综述将重点关注 AD 的两个常见风险因素,即代谢功能障碍和睡眠障碍,并讨论它们与 AD 病理生理学之间关系的潜在机制。睡眠和代谢都可以改变与 AD 相关的蛋白质产生和清除,导致失衡,从而推动 AD 进展。此外,这些风险因素与 AD 之间存在双向关系,AD 相关病理的存在会进一步破坏睡眠并恶化代谢功能。睡眠和代谢之间似乎也存在相互关系,间接加重 AD 的病理生理学。了解这些关系中涉及的机制对于确定减缓 AD 级联反应的新策略至关重要。